Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 220131Generated: October 23, 2026

Piperazine → 4-(3-Carboxy4-chloro-benzenesulfonyl)-piperazine-1-carboxylic acid ethyl ester

https://huagongshe.com/en/reaction/220131

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPiperazineHCID 4837—
Reactant1-Piperazinecarboxylic acid, ethyl esterHCID 8431—
ReactantSulfuryl fluorideHCID 17607—
ReactantDiisopropylethylamineHCID 81531—
Reactant2-Chloro-5-(fluorosulpho)benzoic acidHCID 88873—
SolventEthyl AcetateHCID 8857—
Product4-(3-Carboxy4-chloro-benzenesulfonyl)-piperazine-1-carboxylic acid ethyl esterHCID 4546423180.8%

Reaction Steps

2-Chloro-5-fluorosulfonylbenzoic acid (Acros Organics, 105 mg, 440 μmol, 1.0 eq) was placed in a vial and the vial was flushed with nitrogen and a positive pressure was maintained. Anhydrous dichloromethane (1.4 mL) was added, followed by ethyl 1-piperazine carboxylate (80 μL, 528 μmol, 1.2 eq) and ethyldiisopropylamine (redistilled, 80 μL, 440 μmol, 1.0 eq). The mixture was stirred for 1.5 h after which time additional piperazine was added (60 μL, 352 μmmol, 0.8 eq). After 14 h the mixture was analyzed by reverse-phase HPLC-MS in negative ionization mode. The sulfonyl fluoride starting material was present, as well as a less polar compound showing (M−1) ion in about 35:65 ratio. An additional 0.35 eq of piperazine and ethyldiisopropylamine each (154 μmol, 30 μl) were added and the mixture was stirred for 4 h. HPLC-MS at this time indicated little progress and an additional 0.25 eq of piperazine (100 μmol, 20 μL) was added. After stirring for 14 h HPLC-MS indicated the reaction was complete. The reaction mixture was diluted with 2 mL of ethyl acetate, washed with 1M HCl solution (2×1 mL) and dried over anhydrous sodium sulfate. The solution was filtered, the solvents removed on a rotary evaporator and vacuum pump to afford 134 mg of a white solid, 81%. NOTE: Addition of excess nucleophilic amine at the beginning of the reaction results in significant bis addition, giving sulfonamide and carboxamide product. Stepwise addition of nucleophilic amine as needed suppresses formation of this side product.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08202859B2
Source datasetuspto-grants-2012_06
ORD IDord-d59565de9b4846a199c7c605fe1eebd5
Source noteuspto-grants-2012_06